4//SEC Filing
Bedard John F 4
Accession 0001104659-06-001051
CIK 0001013351other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 7:14 PM ET
Size
10.7 KB
Accession
0001104659-06-001051
Insider Transaction Report
Form 4
Bedard John F
Director
Transactions
- Disposition to Issuer
Employee Stock Option (Right to Buy)
2006-01-04−3,125→ 0 totalExercise: $2.72Exp: 2014-10-04→ Common Stock (3,125 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2006-01-04−25,000→ 0 totalExercise: $1.64Exp: 2015-02-18→ Common Stock (25,000 underlying) - Disposition to Issuer
Employee Stock Option (Right to Buy)
2006-01-04−24,375→ 0 totalExercise: $1.64Exp: 2015-02-18→ Common Stock (24,375 underlying)
Footnotes (7)
- [F1][Reserved]
- [F2]The option vested 100% on date of Grant.
- [F3]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 637 shares of EpiCept common stock for $13.34 per share.
- [F4]The option vested 100% on 9/30/05.
- [F5]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 5,099 shares of EpiCept common stock for $8.05 per share.
- [F6]The option vested 100% on date of Grant.
- [F7]This option was assumed by EpiCept Corporation in the merger and was replaced with an option to purchase 4,971 shares of EpiCept common stock for $8.05 per share.
Documents
Issuer
MAXIM PHARMACEUTICALS INC
CIK 0001013351
Entity typeother
Related Parties
1- filerCIK 0001305387
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 7:14 PM ET
- Size
- 10.7 KB